Breaking News

AMRI to Provide Sterile Fill/Finish Mfg. for AstraZeneca’s COVID-19 Vax

To supply the vaccine candidate AZD1222 from AMRI’s drug product manufacturing facility in Albuquerque, NM.

By: Contract Pharma

Contract Pharma Staff

Albany Molecular Research, Inc. (AMRI), a provider of advanced drug development and manufacturing services, has signed a supply agreement with AstraZeneca to support the manufacture of AstraZeneca’s COVID-19 vaccine candidate AZD1222, intended to protect against the SARS-CoV-2 novel coronavirus. On May 21, 2020, AstraZeneca had received more than $1 billion from the U.S. Biomedical Advanced Research and Development Authority (BARDA) for the development, production and delivery of the COVID-1...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters